Cargando…
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection—a case report
BACKGROUND: Glatiramer acetate is worldwide used as first line treatment in relapsing remitting multiple sclerosis. Local skin reactions associated with glatiramer acetate are common, however, only isolated cases of severe local injection site reactions known as Nicolau Syndrome have been reported s...
Autores principales: | Zecca, Chiara, Mainetti, Carlo, Blum, Roland, Gobbi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668705/ https://www.ncbi.nlm.nih.gov/pubmed/26630967 http://dx.doi.org/10.1186/s12883-015-0504-0 |
Ejemplares similares
-
Nicolau syndrome following subcutaneous glatiramer acetate injection: A case report and review of the literature
por: Esme, Pelin, et al.
Publicado: (2021) -
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
por: Caporro, Matteo, et al.
Publicado: (2014) -
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
por: Vlahova, Lyubomira, et al.
Publicado: (2021) -
Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine
por: Sy, Michael Yu, et al.
Publicado: (2021) -
Case Report: Nicolau syndrome due to etofenamate injection
por: Ozlu, Emin, et al.
Publicado: (2017)